Trials / Recruiting
RecruitingNCT04494295
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Aurora Surgiscope System | MIS evacuation of hematoma using the Aurora Surgiscope System |
Timeline
- Start date
- 2020-10-23
- Primary completion
- 2028-10-15
- Completion
- 2029-10-15
- First posted
- 2020-07-31
- Last updated
- 2026-02-06
Locations
20 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04494295. Inclusion in this directory is not an endorsement.